Citigroup
MDVX

Citigroup’s Medovex Corp. Common Stock MDVX Stock Holding History

Citigroup’s Portfolio MDVX Stock Details MDVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-146
Closed – – 8090
2015
Q3 		$0 Buy
146
+139
+1,986% +$410 ﹤0.01% 8032
2015
Q2 		$0 Buy
+7
New +$28 ﹤0.01% 7943

Other funds holding MDVX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Citigroup's MDVX Position: Q4 2015 in Review

Citigroup sold out of Medovex Corp. Common Stock (MDVX) in Q4 2015, closing a stake of 146 shares.

Citigroup first reported a position in MDVX in Q2 2015 and held it in 2 quarters. The position peaked at $0 in Q3 2015. 6 funds tracked by Wall St. Rank hold MDVX as of Q4 2015.

  • Citigroup reported no remaining Medovex Corp. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Citigroup sold 146 Medovex Corp. Common Stock shares in Q4 2015.
  • Citigroup first reported a position in Medovex Corp. Common Stock in Q2 2015 and held it in 2 quarters.
  • Citigroup's Medovex Corp. Common Stock position peaked at $0 in Q3 2015.
  • 6 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q4 2015.

Based on Citigroup's 13F filing for Q4 2015, filed 12 Feb 2016.